These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29123506)

  • 1. Challenges and Advances for Genetic Engineering of Non-model Bacteria and Uses in Consolidated Bioprocessing.
    Yan Q; Fong SS
    Front Microbiol; 2017; 8():2060. PubMed ID: 29123506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic toolkits for engineering Rhodococcus species with versatile applications.
    Liang Y; Yu H
    Biotechnol Adv; 2021; 49():107748. PubMed ID: 33823269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in systems and synthetic biology approaches for developing novel cell-factories in non-conventional yeasts.
    Patra P; Das M; Kundu P; Ghosh A
    Biotechnol Adv; 2021; 47():107695. PubMed ID: 33465474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 advances engineering of microbial cell factories.
    Jakočiūnas T; Jensen MK; Keasling JD
    Metab Eng; 2016 Mar; 34():44-59. PubMed ID: 26707540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in genetic tools for engineering probiotic lactic acid bacteria.
    Mugwanda K; Hamese S; Van Zyl WF; Prinsloo E; Du Plessis M; Dicks LMT; Thimiri Govinda Raj DB
    Biosci Rep; 2023 Jan; 43(1):. PubMed ID: 36597861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in genetic engineering tools based on synthetic biology.
    Ren J; Lee J; Na D
    J Microbiol; 2020 Jan; 58(1):1-10. PubMed ID: 31898252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
    Shen B; Brown KM; Lee TD; Sibley LD
    mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances of CRISPR/Cas9-Based Genetic Engineering and Transcriptional Regulation in Industrial Biology.
    Zhang S; Guo F; Yan W; Dai Z; Dong W; Zhou J; Zhang W; Xin F; Jiang M
    Front Bioeng Biotechnol; 2019; 7():459. PubMed ID: 32047743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.
    Mondal R; Brahmbhatt N; Sandhu SK; Shah H; Vashi M; Gandhi SK; Patel P
    Cureus; 2023 Dec; 15(12):e50031. PubMed ID: 38186450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 12. CRISPR/Cas9 and genome editing in Drosophila.
    Bassett AR; Liu JL
    J Genet Genomics; 2014 Jan; 41(1):7-19. PubMed ID: 24480743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Editing in Clinical Practice: Where are We?
    Mittal RD
    Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-of-the-Art Genetic Modalities to Engineer Cyanobacteria for Sustainable Biosynthesis of Biofuel and Fine-Chemicals to Meet Bio-Economy Challenges.
    Khan AZ; Bilal M; Mehmood S; Sharma A; Iqbal HMN
    Life (Basel); 2019 Jun; 9(3):. PubMed ID: 31252652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene editing tools for mycoplasmas: references and future directions for efficient genome manipulation.
    Zhao G; Lu D; Li M; Wang Y
    Front Microbiol; 2023; 14():1191812. PubMed ID: 37275127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward Genome-Based Metabolic Engineering in Bacteria.
    Oesterle S; Wuethrich I; Panke S
    Adv Appl Microbiol; 2017; 101():49-82. PubMed ID: 29050667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 Systems for the Development of
    Meng J; Qiu Y; Shi S
    Front Bioeng Biotechnol; 2020; 8():594347. PubMed ID: 33330425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toolboxes for cyanobacteria: Recent advances and future direction.
    Sun T; Li S; Song X; Diao J; Chen L; Zhang W
    Biotechnol Adv; 2018; 36(4):1293-1307. PubMed ID: 29729377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergent CRISPR-Cas-based technologies for engineering non-model bacteria.
    Volke DC; Orsi E; Nikel PI
    Curr Opin Microbiol; 2023 Oct; 75():102353. PubMed ID: 37413959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.